-
<![CDATA[RAD51-Based HRD Test Could Help Refine Patient Selection for Olaparib in BRCA1/2- or PALB2-Mutant, HER2– Breast Cancer ]]>
13 Dec 2025 05:25 GMT
… more likely to benefit from treatment with olaparib (Lynparza), according to data … of the phase 2 RADIOLA trial (NCT05340413).1
Findings presented at … .9%-82.3%), respectively.
“This trial supports the value of a …
-
Understanding Prostate Cancer: Symptoms, Diagnosis And The Newest Treatment Advances
09 Dec 2025 16:18 GMT
… (DRE), where the doctor assesses the prostate gland … and individual patient factors.
Treatment Options
To determine the optimal … PARP Inhibitors:
Targeted drugs such as Olaparib show high effectiveness … the rise of personalized medicine, even advanced cases …
-
CDK4/6 Inhibitor Management After Landmark Trial Success
09 Dec 2025 16:12 GMT
…
Recognizing and Mitigating Common Treatment-Related Side Effects
Huppert … for OlympiA for adjuvant olaparib in hormone-positive … #47;6 inhibitor trials, one trial allowed you to … drug-drug interactions between this class of medicine and other medications …
-
New drug combination shows promise for overcoming resistance in ovarian cancer
04 Dec 2025 17:22 GMT
… PARP inhibitor (such as Olaparib), it killed more … mechanisms. Both drugs are oral, making treatment more accessible, … trials at CU Cancer Center, visit the center's clinical trial … -Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression …
-
From lab to clinic: CU Anschutz launches Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer
04 Dec 2025 16:01 GMT
… mechanisms. Both drugs are oral, making treatment more accessible, … trials at CU Cancer Center, visit the center’s clinical trial … of transformative science, medicine, education and patient … catenin repression synergizes with olaparib to inhibit tumor …
-
Metastatic Cancer Drugs Market Expanding With $74.71 Billion at 5.6% CAGR by 2029
25 Nov 2025 00:00 GMT
… the success of clinical trials, and upgrades in diagnosis … the rise of precision medicine, development of biomarker- … in biotech and pharmaceuticals, launched a drug for breast cancer treatment as … 3) By PARP Inhibitors: Olaparib, Rucaparib, Niraparib
4) By …
-
DNA Repair Drugs Market Size, Share & Trends Analysis Report By Product
24 Nov 2025 09:30 GMT
… concentration on precision medicine, a growing elderly … plc.
• Takeda Pharmaceutical Company Limited
What Are … By Drug Type: Olaparib, Rucaparib, Niraparib, Talazoparib, Other Drugs
2 … Combination with Other Cancer Treatments
3) By Niraparib …
-
Simple blood test may be a better guide treatment for ovarian cancer
12 Nov 2025 15:37 GMT
… for Translational Research and Clinical Trials (ATRACT) Centre.
" … who is also a medical oncologist at the Peter … treatment benefit we saw with this approach, the small trial … for her."
'Olaparib, durvalumab, and cyclophosphamide, and …
-
Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China
11 Nov 2025 15:44 GMT
… bid to supply Olaparib tablets.
Also, Kunshan Rotam Reddy Pharmaceutical Co, a … covered 55 drugs across anti-infectives, anti-tumour treatments, allergy treatments, and other … the small molecule drug sales in the Chinese pharmaceutical market with sales …
-
Real-World Treatment Patterns and Overall Survival (OS) of Patients with Metastatic Castration-Resistant Prostate Cancer in Italy
11 Nov 2025 00:02 GMT
… data; pharmaceuticals database, for information on drug prescriptions, … physician-reported data stating that 42% of … who are co-developing Olaparib. Medical writing and editorial … prostate cancer treatment: a review of literature and ongoing trials. Discov …